Anden antiretroviral behandling end REYATAZ kan overvejes såfremt gulsot eller scleral icterus ikke er acceptabelt for patienten.
Alternative antiretroviral therapy to REYATAZ may be considered if jaundice or scleral icterus is unacceptable to a patient.